Pyrhönen SO - Search Results

1

Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study.

Halme M, Maasilta PK, Pyrhönen SO, Mattson KV. Halme M, et al. Among authors: pyrhonen so. Eur J Cancer. 1994;30A(1):11-5. doi: 10.1016/s0959-8049(05)80009-7. Eur J Cancer. 1994. PMID: 8142151 Clinical Trial.

2

Natural interferon alfa as maintenance therapy for small cell lung cancer.

Mattson K, Niiranen A, Pyrhönen S, Holsti LR, Holsti P, Kumpulainen E, Cantell K. Mattson K, et al. Eur J Cancer. 1992;28A(8-9):1387-91. doi: 10.1016/0959-8049(92)90526-8. Eur J Cancer. 1992. PMID: 1325176 Clinical Trial.

3

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.

Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhönen S. Niiranen A, et al. J Clin Oncol. 1992 Dec;10(12):1927-32. doi: 10.1200/JCO.1992.10.12.1927. J Clin Oncol. 1992. PMID: 1333518 Clinical Trial.

4

Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation.

Mattson K, Holsti LR, Tammilehto L, Maasilta P, Pyrhönen S, Mäntylä M, Kajanti M, Salminen US, Rautonen J, Kivisaari L. Mattson K, et al. Int J Radiat Oncol Biol Phys. 1992;24(4):643-50. doi: 10.1016/0360-3016(92)90709-q. Int J Radiat Oncol Biol Phys. 1992. PMID: 1429086 Clinical Trial.

5

Recombinant interferon gamma treatment in non-small cell lung cancer. Antitumour effect and cardiotoxicity.

Mattson K, Niiranen A, Pyrhönen S, Färkkilä M, Cantell K. Mattson K, et al. Acta Oncol. 1991;30(5):607-10. doi: 10.3109/02841869109092427. Acta Oncol. 1991. PMID: 1654065

6

A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer.

Niitamo-Korhonen S, Holsti P, Holsti LR, Pyrhönen S, Mattson K. Niitamo-Korhonen S, et al. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1039-43. doi: 10.1016/0277-5379(89)90385-4. Eur J Cancer Clin Oncol. 1989. PMID: 2547622 Clinical Trial.

7

A phase II trial of docetaxel in advanced non-small cell lung cancer.

Saarinen A, Jekunen A, Halme M, Pyrhönen S, Tamminen K, Boyer R, Roubille N, Mattson K. Saarinen A, et al. Anticancer Drugs. 1996 Nov;7(8):890-2. doi: 10.1097/00001813-199611000-00012. Anticancer Drugs. 1996. PMID: 8991195 Clinical Trial.

8

Interferon maintenance therapy for small cell lung cancer: improvement in long-term survival.

Mattson K, Niiranen A, Ruotsalainen T, Maasilta P, Halme M, Pyrhönen S, Kajanti M, Mäntylä M, Tamminen K, Jekunen A, Sarna S, Cantell K. Mattson K, et al. J Interferon Cytokine Res. 1997 Feb;17(2):103-5. doi: 10.1089/jir.1997.17.103. J Interferon Cytokine Res. 1997. PMID: 9058316 Clinical Trial.

9

Concomitant chemotherapy and IFN-alpha for small cell lung cancer: a randomized multicenter phase III study.

Ruotsalainen TM, Halme M, Tamminen K, Szopinski J, Niiranen A, Pyrhönen S, Riska H, Maasilta P, Jekunen A, Mäntylä M, Kajanti M, Joensuu H, Sarna S, Cantell K, Mattson K. Ruotsalainen TM, et al. J Interferon Cytokine Res. 1999 Mar;19(3):253-9. doi: 10.1089/107999099314180. J Interferon Cytokine Res. 1999. PMID: 10213464 Clinical Trial.

10

Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.

Ruotsalainen T, Halme M, Isokangas OP, Pyrhönen S, Mäntylä M, Pekonen M, Sarna S, Joensuu H, Mattson K. Ruotsalainen T, et al. Anticancer Drugs. 2000 Feb;11(2):101-8. doi: 10.1097/00001813-200002000-00006. Anticancer Drugs. 2000. PMID: 10789592 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters